Dialysis solutions comprising organic esters of phosphoric acid

Patent metadata

Field	Value
Publication number	US-9629858-B2
Application number	US-201615182774-A
Country	US
Kind code	B2
Filing date	Jun 15, 2016
Priority date	Jun 16, 2015
Publication date	Apr 25, 2017
Grant date	Apr 25, 2017

Abstract

This document relates to bi-carbonate-buffered dialysis solutions with physiological phosphate content and increased stability. The solutions include an organic ester of phosphoric acid, calcium ions and/or magnesium ions, and optionally additional electrolytes, buffers and glucose in physiologically effective concentrations.

First claim

What is claimed is:

1. A dialysis solution, comprising:
bicarbonate ions;
one or more of calcium and magnesium ions; and
an organic ester of phosphoric acid, wherein the organic ester of phosphoric acid is glycerol orthophosphate.

2. The dialysis solution of claim 1 , wherein the concentration of the organic ester of phosphoric acid is 0.8 to 1.25 mmol/L with respect to the phosphate.

3. The dialysis solution of claim 2 , wherein the concentration of the organic ester of phosphoric ester is 1 to 1.2 mmol/L with respect to the phosphate.

4. The dialysis solution of claim 1 , further comprising one or more of an electrolyte and an osmotic agent, wherein the electrolyte is selected from the group consisting of sodium ions, potassium ions, and chloride ions, and wherein the osmotic agent is a saccharide or a saccharide derivative.

5. The dialysis solution of claim 1 , further comprising orthophosphate, wherein the concentration of the orthophosphate is about 0.1 to 0.3 mmol/L.

6. The dialysis solution of claim 5 , wherein the concentration of the orthophosphate is about 0.1 to 0.2 mmol/L.

7. The dialysis solution of claim 5 , further comprising one or more of an electrolyte and an osmotic agent, wherein the electrolyte is selected from the group consisting of sodium ions, potassium ions, and chloride ions, and wherein the osmotic agent is a saccharide or a saccharide derivative.

8. A plurality of solution components to be mixed to form a solution, wherein the solution comprises:
bicarbonate ions;
one or more of calcium and magnesium ions;
an organic ester of phosphoric acid; and
optionally one or more of orthophosphate, an electrolyte, and an osmotic agent, wherein the organic ester of phosphoric acid is glycerol orthophosphate.

9. The plurality of solution components of claim 8 , wherein the plurality of solution components comprise a first solution component and a second solution component, wherein the second solution component comprises the organic ester of phosphoric acid and optionally the orthophosphate.

10. The plurality of solution components of claim 9 , wherein the first solution component is contained in a first chamber of a container, and the second solution component is contained in a second chamber of the container.

11. The plurality of solution components of claim 9 , wherein the first solution component comprises one or more of calcium ions and magnesium ions; and the second solution component does not contain any calcium ions or magnesium ions.

12. The plurality of solution components of claim 11 , wherein the first solution component further comprises chloride ions, an osmotic agent and optionally potassium ions; and wherein the second solution component further comprises sodium ions, chloride ions, and bicarbonate ions.

13. The plurality of solution components of claim 12 , wherein the first solution component does not contain bicarbonate ions, organic esters of phosphoric acid, orthophosphate and sodium ions.

14. The plurality of solution components of claim 12 , wherein the second solution component does not contain calcium ions, magnesium ions, potassium ions, and osmotic agents.

15. The plurality of solution components of claim 9 , wherein the first solution component has a pH of about 2.4 to 3.0; and the second solution component has a pH of about 7.0 to 7.8.

Assignees

• Fresenius Medical Care Deutschland Gmbh

Inventors

• Huppert Jochen
• Mathis Pascal
• Berlich Robert
• Pohlmeier Robert

Classifications

• A61P7/08

  Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock (artificial tears A61P27/04) · CPC title

• A61J1/10

  Bag-type containers · CPC title

• A61M1/1654

  Dialysates therefor · CPC title

• B65D31/12

  with two or more compartments · CPC title

• A61K33/06

  Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay} · CPC title